Concepedia

Recurrence Treatment

Recurrence Treatment is a clinical intervention strategy, within the domain of ovarian cancer pharmacotherapy, that specifically addresses the management of disease reappearance following initial remission, distinguished from primary treatment by its focus on therapeutic adaptation to prior treatment exposure and disease evolution.

169

Publications

8.1K

Citations

1.4K

Authors

589

Institutions

Publications per year

2017–2026

65

Parents

Publications

169

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

Gordon Rustin, Maria EL van der Burg, Clare Griffin et al. · The Lancet · 2010 · 594 citations · Full text

, , +15

Improved Results of Liver Resection for Hepatocellular Carcinoma on Cirrhosis Give the Procedure Added Value

Gian Luca Grazi, Giorgio Ercolani, Filippo Pierangeli et al. · Annals of Surgery · 2001 · 341 citations · Full text

, , +16

Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial

Bradley J. Monk, Andrés Poveda, Ignace Vergote et al. · The Lancet Oncology · 2014 · 305 citations

, , +15

Reactivation of Retinopathy of Prematurity After Bevacizumab Injection

Jennifer Hu, Michael P. Blair, Michael J. Shapiro et al. · Archives of Ophthalmology · 2012 · 303 citations

, , +11

The Roswell Park Cancer Institute experience with extramammary Paget’s disease

Joseph D. Zollo, Nathalie C. Zeitouni · British Journal of Dermatology · 2000 · 289 citations

, , +11

1–5 of 169

Authors

1.4K

  1. IV
    Ignace Vergote

    KU Leuven, Belgium

    10 publications · 1K citations

    9

    h-index

  2. UA
    Ursula A. Matulonis

    Dana-Farber Cancer Institute, United States

    6 publications · 336 citations

    6

    h-index

  3. JA
    Jonathan A. Ledermann

    University College London, United Kingdom

    6 publications · 394 citations

    6

    h-index

  4. AM
    Amit M. Oza

    Princess Margaret Cancer Centre, Canada

    5 publications · 489 citations

    5

    h-index

  5. JS
    Jalid Sehouli

    Charité - Universitätsmedizin Berlin, Germany

    6 publications · 409 citations

    5

    h-index

1–5 of 1.4K

Institutions

589

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    10 h-index

    57 publications

    3.2K citations

  2. Dana-Farber Cancer Institute

    Boston, United States

    8 h-index

    20 publications

    891 citations

  3. University College London

    London, United Kingdom

    7 h-index

    22 publications

    2.5K citations

  4. Radboud University Nijmegen

    Nijmegen, The Netherlands

    7 h-index

    26 publications

    1.6K citations

  5. Chinese Academy of Medical Sciences & Peking Union Medical College

    Beijing, China

    6 h-index

    38 publications

    955 citations

  6. Fondazione IRCCS Istituto Nazionale dei Tumori

    Milan, Italy

    6 h-index

    6 publications

    556 citations

  7. Charité - Universitätsmedizin Berlin

    Berlin, Germany

    5 h-index

    13 publications

    869 citations

  8. Massachusetts General Hospital

    Boston, United States

    5 h-index

    16 publications

    662 citations

1–8 of 589

Venues

  1. Journal of Clinical Oncology

    15 publications · 566 citations

    14

    h-index

  2. Gynecologic Oncology

    14 publications · 578 citations

    13

    h-index

  3. PubMed

    Repository · 17 publications · 476 citations

    13

    h-index

  4. International Journal of Gynecological Cancer

    7 publications · 166 citations

    7

    h-index

  5. The Journal of Urology

    4 publications · 157 citations

    4

    h-index

1–5